OSP News

CDC Updates Respiratory Syncytial Virus (RSV) Vaccine Recommendation

Posted: 06/27/2024

CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends the following populations receive the vaccine:

  • Everyone ages 75 and older 
  • People ages 60–74 who are at increased risk of severe RSV (certain chronic medical conditions like lung or heart disease, or residing in nursing homes) 

CDC recommends that older adults who were not immunized against respiratory syncytial virus (RSV) last year, do so late this summer and early fall, ahead of the upcoming RSV season. The RSV vaccine currently is not administered on an annual basis; therefore, anyone who was immunized in 2023 is still covered.

CDC updated its recommendations based on cost-effectiveness and vaccine efficacy research plus analyses of disease burden in older adults. 

Click here for more information.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.


OSP Technical Support